X0306 4 2021-11-03-05:00 false 0000093314 VOLITIONRX LTD VNRX 0001579377 Innes Guy Archibald 13215 BEE CAVE PARKWAY SUITE 125 GALLERIA OAKS B AUSTIN TX 78738 true false false false Stock Option (Right to Buy) 4.00 2021-11-03-05:00 4 D false 30000 D 2017-04-15-05:00 2022-04-15-05:00 Common Stock 30000 0 D Stock Option (Right to Buy) 4.00 2021-11-03-05:00 4 A false 30000 A 2017-04-15-05:00 2026-04-15-05:00 Common Stock 30000 30000 D Stock Option (Right to Buy) 5.00 2021-11-03-05:00 4 D false 20000 D 2018-03-30-05:00 2023-03-30-05:00 Common Stock 20000 0 D Stock Option (Right to Buy) 5.00 2021-11-03-05:00 4 A false 20000 A 2018-03-30-05:00 2027-03-30-05:00 Common Stock 20000 20000 D Stock Option (Right to Buy) 4.00 2021-11-03-05:00 4 D false 20000 D 2019-01-23-05:00 2024-01-23-05:00 Common Stock 20000 0 D Stock Option (Right to Buy) 4.00 2021-11-03-05:00 4 A false 20000 A 2019-01-23-05:00 2028-01-23-05:00 Common Stock 20000 20000 D The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on April 15, 2016, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on April 15, 2026 (ten years from the original date of grant). The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on March 30, 2017, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on March 30, 2027 (ten years from the original date of grant). The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on January 23, 2018, vested in full and were exercisable at 12 months from the date of grant, and were exercisable for five years from the date first exercisable. The "replacement" options are fully-vested and expire on January 23, 2028 (ten years from the original date of grant). /s/ Guy Archibald Innes 2021-11-05-05:00